← SynDRA
peficitinib
SynDRA canonical compound SYN0041276 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | JAK1 | JAK2 | JAK3 |
|---|
| Mechanism of action | JAK inhibitor |
|---|
| Indication | rheumatoid arthritis |
|---|
| Disease area | rheumatology |
|---|
All known targets
Mechanisms of action (all sources)
- JAK inhibitor
- JAK3 INHIBITOR
- JAK1 INHIBITOR
- JAK2 INHIBITOR
- TYK2 INHIBITOR
Drug classes
- Enzyme Inhibitors
- Immunologic Factors
- Immunosuppressive Agents
ATC classes
Cross-references
Synonyms
- peficitinib hydrobromide
- smyraf
- ASP015K
- JNJ-54781532
- ASP 015K
- Peficitinib free base
- HPH1166CKX
- Peficitinib [USAN:INN]
- UNII-HPH1166CKX
- 9T6
- Peficitinib [USAN]
- Peficitinib (Standard)
- PEFICITINIB [INN]
- Peficitinib (USAN/INN)
- PEFICITINIB [WHO-DD]
- GTPL8315
- orb1300333
- SCHEMBL1154418
- SCHEMBL1154421
- SCHEMBL4447032
- SCHEMBL9990240
- SCHEMBL9990248
- SCHEMBL17645135
- SCHEMBL29351094
- BDBM50124208
- BDBM50622128
- HY-19568R
- PEFICITINIB HYDROBROMIDE [JAN]
- CS-5393
- PeficitinibASP015K,JNJ-54781532
- HY-19568
- MS-24878
- PD162379
- PeficitinibASP015K,JNJ-54781532?
- ASP015K; JNJ-54781532
- NS00073757
- D10653
- BRD-K21225231-001-01-2
Look up peficitinib in the interactive SynDRA portal →